PSA Rising Prostate Medical News

Main Menu

Treatments

Blogs

Wednesday, October 14 2009 00:00

Shorter and Safer Hospital Stays But More Risk of Incontinence and Erectile Dysfunction, Study Shows

New research indicates that the use of minimally invasive procedures (including the use of robotic assistance) for radical prostatectomy, which have increased significantly in recent years, may shorten hospital stays and decrease respiratory and surgical complications, but may also result in an increased rate of certain complications, including incontinence and erectile dysfunction, according to a study in the October 14 issue of JAMA

Cancer May Lower HDL Cholesterol, Study Finds

Cancer may lower good, HDL cholesterol and low total cholesterol may be a sign of undiagnosed cancer, a long-running study following nearly thirty thousand men for almost 20 years has discovered. A related study suggests that lowering total cholesterol may help men reduce risk of high-grade prostate cancer.

Men with low cholesterol face less risk of high-grade prostate cancer

Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer — an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.

Shorter Radiation Course Stops Cancer Growth in High-risk Prostate Cancer Patients

Hypofractionated radiation treatment, a newer type of radiation treatment that delivers higher doses of radiation in fewer treatments than conventional radiation therapy, is significantly more effective than the older method in stopping cancer growth in high risk patients and causes no increase in negative side effects, an Italian clinical trial shows.

Short Course High-Dose Radiation (IMRT) Looks Safe and Effective for Higher-Risk Prostate Cancer

ASTRO - A shorter, 5-week course of radiation treatment that delivers higher doses of radiation in fewer sessions, known as hypofractionation, appears just as effective and as safe for moderate and higher risk prostate cancer as standard radiation therapy, yet is delivered in two-and-a-half weeks less time.